Fig. 1 · Structure

Documents & Downloads

Isochlorogenic acid C

Cat. No. A12074 CAS 32451-88-0
Isochlorogenic acid B is derived from the flowerbud of Lonicera japonica Thunb.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Isochlorogenic acid C Research Summary

This section summarizes 3 in vitro studies and 1 in vivo study of Isochlorogenic acid C from 3 published references. In vitro models include HEKn/THP-1 co-culture; chicken primary duodenal epithelial cells.

Isochlorogenic acid C In Vitro Studies

In HEKn/THP-1 co-culture, Isochlorogenic acid C pretreatment significantly inhibited VD3-induced proinflammatory cytokine expression compared with the VD3-treated control. In chicken primary duodenal epithelial cells exposed to tert-butyl hydroperoxide, Isochlorogenic acid C pretreatment produced significantly higher cell viability than the model and CGA groups. In HMEC-1 cells, Isochlorogenic acid C pretreatment significantly inhibited LL-37-induced migration compared with the LL-37-treated control. [1,2]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Proinflammatory Cytokine Inhibition in Keratinocyte Co-culture

Cell-based study · HEKn/THP-1 co-culture [1]

In HEKn/THP-1 co-culture, upper inserts were pretreated with Isochlorogenic acid C at 1, 10, or 50 µM before VD3 treatment. Isochlorogenic acid C significantly inhibited VD3-induced proinflammatory cytokine expression compared with the VD3-treated control.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
the secreted pro-inflammatory cytokines (TNF-α, IL-1β) were measured by ELISAReported result Upper insert was pretreated with 1, 10, or 50 µM isochlorogenic acids A and isochlorogenic acid C, respectively, for 1 h, followed by treatment with 200 nM VD3. The chlorogenic acid isomers A and C exhibited significant inhibitory effects on the expression of proinflammatory cytokines induced by VD3 in HEKn/THP-1 co-culture conditions.[1]

Literature-Reported Treatment Conditions

Treatment concentration
1, 10, or 50 µM
Exposure duration
for 1 h, followed by treatment with 200 nM VD3. After 72 h incubation
Method
Upper insert was pretreated
Co-treatment
Other interventions in this design: VD3 200 nM; phorbol 12-myristate 13-acetate, PMA 100 nM. Compound effect isolated by the comparison: vs. VD3-treated control.
Reported limits
Not stated in the sentences used: vehicle.
Methods and source locations

Compound reported in the paper: Isochlorogenic acid C

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

2. Materials and Methods > 2.10. Co-Culture Conditions > 2.10.1. HEKn/THP-1 Co-Culture (S41, S44); 2. Materials and Methods > 2.10. Co-Culture Conditions > 2.10.2. HEKn/MC/9 Co-Culture (S47); 3. Results > 3.4. Chlorogenic Acid Isomers Decrease the Expression of Proinflammatory Cytokines Induced by VD3 (S98); Figure 3 legend (S138); Figure 4 legend (S142, S144, S145, S146)

the secreted pro-inflammatory cytokines (TNF-α, IL-1β) were measured by ELISA: the secreted pro-inflammatory cytokines (TNF-α, IL-1β) were measured by ELISA; comparator: VD3-treated control — 3. Results > 3.4. Chlorogenic Acid Isomers Decrease the Expression of Proinflammatory Cytokines Induced by VD3 (S98); Figure 4 legend (S144, S145)

Cell viability in chicken duodenal epithelial cells

Cell-based study · chicken primary duodenal epithelial cells [2]

Chicken primary duodenal epithelial cells received Isochlorogenic acid C pretreatment in a design involving tert-butyl hydroperoxide. At 100 μM, pretreatment with isochlorogenic acids A, B, and C yielded significantly higher cell viability than the model and CGA groups.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
cell viabilityReported result at 100 μM, the cell viability of isochlorogenic acid A, B, and C pretreatment was significantly higher than that of the model and CGA groups (P < 0.05)[2]

Literature-Reported Treatment Conditions

Treatment concentration
100 μM
Method
pretreatment
Co-treatment
Other interventions in this design: tert-butyl hydroperoxide (tBHP) 400 μM. Compound effect isolated by the comparison: model and CGA groups.
Reported limits
Not stated in the sentences used: schedule, vehicle.
Methods and source locations

Compound reported in the paper: Isochlorogenic acid C

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

MATERIALS AND METHODS > Experimental Design > Comparison of the Antioxidant Effects of Chlorogenic Acid and Its Isomers In Vitro (S2, S4); MATERIALS AND METHODS > Cell Viability Assay (S36); RESULTS > Initial Screening of the Antioxidant Capacity of Chlorogenic Acid Isomers (S119)

cell viability: cell viability; comparator: model and CGA groups — RESULTS > Initial Screening of the Antioxidant Capacity of Chlorogenic Acid Isomers (S119)

Endothelial Cell Migration Following LL-37 Treatment

Cell-based study · HMEC-1 (2 × 105 cells/well) [1]

HMEC-1 cells were pretreated with Isochlorogenic acid C at 1, 10, and 50 µg/mL before LL-37 treatment. Isochlorogenic acid C significantly inhibited LL-37-induced migration compared with the LL-37-treated control.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
the migration was measured by analyzing the images of cells filling the scratchReported result The cells were pretreated with isochlorogenic acid A or isochlorogenic acid C (1, 10, and 50 µg/mL), followed by treatment with 5 µg/mL LL-37. Both isochlorogenic acids A and C significantly inhibited the migration of HMEC-1 induced by LL-37.[1]

Literature-Reported Treatment Conditions

Treatment concentration
1, 10, and 50 µg/mL
Exposure duration
After 48 h of incubation
Method
pretreated
Co-treatment
Other interventions in this design: LL-37 5 µg/mL; scratched using a sterile pipette tip. Compound effect isolated by the comparison: vs. LL-37-treated control.
Reported limits
Not stated in the sentences used: vehicle.
Methods and source locations

Compound reported in the paper: Isochlorogenic acid C

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

2. Materials and Methods > 2.13. HMEC-1 Migration Assay (S62, S63, S65, S66); 3. Results > 3.6. Isochlorogenic Acid Isomers Regulate LL-37-Induced Vascular Endothelial Cell Activation (S124); Figure 3 legend (S140); Figure 6 legend (S156, S161)

the migration was measured by analyzing the images of cells filling the scratch: the migration was measured by analyzing the images of cells filling the scratch; comparator: LL-37-treated control — 2. Materials and Methods > 2.13. HMEC-1 Migration Assay (S65, S66); 3. Results > 3.6. Isochlorogenic Acid Isomers Regulate LL-37-Induced Vascular Endothelial Cell Activation (S124)

Isochlorogenic acid C In Vivo Studies

Male ICR mice with CCl4-induced renal fibrosis received Isochlorogenic acid C intragastrically once daily. MDA measurements in the CCl4 plus Isochlorogenic acid C groups were 0.42 ± 0.04 mol/mg Protein at 10 mg/kg and 0.36 ± 0.04 mol/mg Protein at 20 mg/kg. [3]

Renal MDA measurements in mice with induced fibrosis

Animal study · male 8-week-old ICR mice; CCl4-induced renal fibrosis; n = 7 for biochemical analyses [3]

Male ICR mice with CCl4-induced renal fibrosis received Isochlorogenic acid C intragastrically once daily. MDA measurements in the CCl4 plus Isochlorogenic acid C groups were 0.42 ± 0.04 mol/mg Protein at 10 mg/kg and 0.36 ± 0.04 mol/mg Protein at 20 mg/kg.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
MDA (mol/mg Protein)MDA 0.42 ± 0.04 mol/mg Protein; 0.36 ± 0.04 mol/mg Protein[3]

Conditions shared by the study groups

Route
intragastrically
Treatment course
once daily; 4 weeks; CCl4 solution 2 mL/kg was injected intraperitoneally twice per week for 4 weeks
Vehicle
normal saline
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Isochlorogenic acid C 10 or 20 mg/kgCCl4 groupCCl4 + IaC (10 mg/kg): 0.42 ± 0.04 mol/mg Protein; CCl4 + IaC (20 mg/kg): 0.36 ± 0.04 mol/mg Protein[3]
Isochlorogenic acid C 10 or 20 mg/kg
Model: male 8-week-old ICR mice; CCl4-induced renal fibrosis; n = 7 for biochemical analyses
Methods and source locations

Compound reported in the paper: Isochlorogenic acid C

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

2. Methods > 2.2. Animal Experiment Design and Ethics (S6, S10, S11, S14, S15, S17); 3. Results > 3.4. IaC Rescued Oxidative Stress in Kidneys (S87); Table 2 legend (S187); Table 2 (T2.h1, T2.r3, T2.r4)

MDA (mol/mg Protein): MDA (mol/mg Protein); comparator: CCl4 group — Table 2 (T2.h1, T2.r3, T2.r4)

Isochlorogenic acid C 10 or 20 mg/kg · 2. Methods > 2.2. Animal Experiment Design and Ethics (S10, S15, S17); Table 2 (T2.h1, T2.r3, T2.r4)

Specifications

Manufacturer Adooq Bioscience
CAS Number 32451-88-0
Formula C25H24O12
Molecular Weight 516.45
SMILES
C[C@@]1(C[C@H]([C@@H]([C@@H](C1)OC(=O)C=CC2=CC(=C(C=C2)O)O)CC(=O)C=CC3=CC(=C(C=C3)O)O)O)C(=O)O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Isochlorogenic acid C Research References

  1. [1] Roh KB, Jang Y, Cho E, et al. Chlorogenic Acid Isomers Isolated from Artemisia lavandulaefolia Exhibit Anti-Rosacea Effects In Vitro. Biomedicines (2022). PMID: 35203672 DOI: 10.3390/biomedicines10020463 Source material
  2. [2] Song D, Zhang S, Chen A, et al. Comparison of the effects of chlorogenic acid isomers and their compounds on alleviating oxidative stress injury in broilers. Poult Sci (2024). PMID: 38552567 DOI: 10.1016/j.psj.2024.103649 Source material
  3. [3] Ma J, Jiang Y, Zhou M, et al. Isochlorogenic Acid C Mitigates CCl4-Induced Kidney Ferroptosis, Inflammation, and Fibrogenesis in Mice: Involvement of the SESN2/MAPKs and Hippo Pathways. Antioxidants (Basel) (2026). PMID: 42939923 DOI: 10.3390/antiox15101349 Source material

Added to your cart

View Cart Checkout
Loading...